Related Experiment Video

Updated: Jun 10, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Molecular changes in myocardium in the course of anemia or iron deficiency

Ewa A Jankowska1, Piotr Ponikowski

  • 1Department of Heart Diseases, Wroclaw Medical University, Centre for Heart Diseases, Military Hospital, ul Weigla 5, Wroclaw 50-981, Poland. ewa@antro.pan.wroc.pl

Heart Failure Clinics
|July 16, 2010
PubMed

Insights

Untreated anemia and iron deficiency (ID) can cause chronic heart failure (CHF). Therapies targeting iron metabolism or erythropoietin signaling may offer novel cardioprotective strategies for CHF patients.

Area of Science:

  • Cardiology
  • Hematology
  • Molecular Biology

Background:

  • Anemia and iron deficiency (ID) are increasingly recognized complications in chronic heart failure (CHF).
  • These conditions can lead to detrimental cardiac changes, including increased cardiac output, sympathetic activation, and left ventricular remodeling.

Purpose of the Study:

  • To explore the role of anemia and ID in the pathogenesis of CHF.
  • To investigate the potential of therapeutic interventions targeting erythropoietin signaling and iron metabolism as novel approaches for managing CHF.

Main Methods:

  • Review of existing literature and experimental models examining the impact of anemia and ID on cardiac function.
  • Analysis of molecular pathways involved in iron metabolism and erythropoiesis relevant to myocardial protection.

Main Results:

  • Chronic anemia and ID contribute to cardiac dysfunction and structural changes in CHF.
  • Pharmacological modulation of erythropoietin signaling and iron correction may activate protective pathways against myocardial remodeling.

Conclusions:

  • Anemia and iron deficiency represent significant contributors to the progression of chronic heart failure.
  • Targeting iron metabolism and erythropoietin pathways presents a promising, albeit largely preclinical, therapeutic avenue for cardioprotection in CHF.
  • Further clinical studies are essential to validate these findings in patient populations.

More Related Videos

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes08:19

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes

Published on: June 22, 2020

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...